These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3499478)

  • 1. Specific plasminogen activator inhibitor of placental type PAI 2 occurring in amniotic fluid and cord blood.
    Lecander I; Astedt B
    J Lab Clin Med; 1987 Nov; 110(5):602-5. PubMed ID: 3499478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
    Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
    Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The plasminogen-activating system in gingival fluid from adults. An intra-individual study before and after treatment of gingivitis.
    Kinnby B; Matsson L; Lecander I
    Scand J Dent Res; 1994 Dec; 102(6):334-41. PubMed ID: 7871356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex congenital malformations and the impact of the plasminogen activator system and beta-hCG in amniotic fluid.
    Verkleij-Hagoort AC; Ursem NT; Hop WC; Geurts-Moespot A; Steegers EA; Sweep FC; Steegers-Theunissen RP
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):47-52. PubMed ID: 17141398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy.
    Booth NA; Reith A; Bennett B
    Thromb Haemost; 1988 Feb; 59(1):77-9. PubMed ID: 3129811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of matrix metalloproteinase-9/tissue inhibitors of matrix metalloproteinase -1 imbalance in maternal serum, amniotic fluid, umbilical cord serum in patients with premature rupture of the membranes].
    Lu D; Wang ZX; Wang XL; Gu XW; Wang YX; Fu D
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):20-4. PubMed ID: 16635322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galanin concentrations in maternal circulation, amniotic fluid and umbilical cord blood during term labor: relationship with maternal body mass and neonatal birth weight.
    Zamłyński J; Chudek J; Olejek A; Kobylec-Zamłyńska B; Mańka G; Bodzek P; Wiecek A
    Gynecol Endocrinol; 2007 May; 23(5):295-9. PubMed ID: 17558689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of leptin and neuropeptide Y in maternal plasma, umbilical cord blood and in amniotic fluid in pregnant women with EPH-gestosis.
    Kokot F; Ulman I; Wiecek A; Irzyniec T; Ulman J
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):311-6. PubMed ID: 9832071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy-specific beta 1-glycoprotein in amniotic fluid in high risk late pregnancy.
    Heikinheimo M
    Oncodev Biol Med; 1980; 1(4-5):287-90. PubMed ID: 6974344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen heterogeneity in homozygous plasminogen deficiency type I: further evidence that plasmin is not involved in formation of LMW- and LMW'-fibrinogen.
    Dempfle CE; Pfitzner SA; Schott D; Niessen KH; Heene DL
    Thromb Haemost; 1997 May; 77(5):879-83. PubMed ID: 9184396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R; Umemura K; Hashimmoto H; Urano T
    Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancy.
    Teramo KA; Widness JA; Clemons GK; Voutilainen P; McKinlay S; Schwartz R
    Obstet Gynecol; 1987 May; 69(5):710-6. PubMed ID: 3574798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum, amniotic fluid and cord leptin levels at term: their correlations with fetal weight.
    Oktem O; Dedeoğlu N; Oymak Y; Sezen D; Köksal L; Pekin T; Gökaslan H; Kavak ZN
    J Perinat Med; 2004; 32(3):266-71. PubMed ID: 15188803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular localisation in placenta of placental type plasminogen activator inhibitor.
    Astedt B; Hägerstrand I; Lecander I
    Thromb Haemost; 1986 Aug; 56(1):63-5. PubMed ID: 3535159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation.
    Gilabert J; Estellés A; Ayuso MJ; España F; Chirivella M; Grancha S; Micó JM; Aznar J
    Gynecol Obstet Invest; 1994; 38(3):157-62. PubMed ID: 8001867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis.
    Yoon BH; Romero R; Park JS; Kim M; Oh SY; Kim CJ; Jun JK
    Am J Obstet Gynecol; 2000 Nov; 183(5):1124-9. PubMed ID: 11084553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentrations of polyamines in maternal and umbilical-cord blood and in the amniotic fluid during normal human pregnancy and in feto-placental insufficiency].
    Casti A; Salvadori B; Reali N; Ferrari B; Orlandini G; Corti A
    Ateneo Parmense Acta Biomed; 1979; 50(1):15-26. PubMed ID: 551770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental anticoagulant protein-I: measurement in extracellular fluids and cells of the hemostatic system.
    Flaherty MJ; West S; Heimark RL; Fujikawa K; Tait JF
    J Lab Clin Med; 1990 Feb; 115(2):174-81. PubMed ID: 2137157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.